TechCrunch
MARCH 2, 2022
It coincides with CISA’s warning, and highlights critical areas of concern for the sector and how they mirror trends amongst pharmaceutical and financial companies, providing vital insight into where organizations can focus their efforts, and reinforce the digital perimeter.
TechCrunch
JULY 19, 2022
In practice, this could mean that marketing teams test-driving third-party social media management tools could inadvertently jeopardise the company’s Twitter and Facebook accounts, or admins could dabble with mobile device management (MDM) software and create an easy inroad for hackers to deploy malware to mobile devices across the workforce.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Infinidat
OCTOBER 4, 2023
The impact may not always be so drastic, although it can be in mission-critical situations, which large enterprises have, whether a health system, a governmental body, a financial institution, a retailer, a utility, a large university, a pharmaceutical company or countless other enterprise organizations. Be vigilant! #3
Infinidat
FEBRUARY 22, 2023
The impact may not always be so drastic, although it can be in mission-critical situations, which large enterprises usually have, whether a health system, a government body, a financial institution, a retailer, a utility, a large university, a pharmaceutical company or countless other types of organizations.
Tenable
DECEMBER 29, 2023
At Tenable, we believe the conventional approaches to securing OT environments are not serving to reduce risk in essential sectors, such as manufacturing, transportation, food and pharmaceutical supply chains, and power and water utilities.
Palo Alto Networks
MARCH 6, 2020
This article tells a customer story of a large pharmaceutical company who could easily have missed the signs of an incoming cyberattack after its endpoint agents failed. The story begins at a large pharmaceutical company that had Cortex XDR deployed using firewalls as sensors to analyze their network traffic. A Sign of Attack.
The Parallax
JULY 20, 2018
He then attempted to call Martin Shkreli, the pharmaceutical company millionaire CEO who bought the patent of the trade name of pyrimethamine, Daraprim, for $55 million and raised the price by 5,500 percent. My biggest fear is that we might be seeing malware on these devices sooner than we think. Biohacking in the real world.
Expert insights. Personalized for you.
246 
Let's personalize your content